Result of General Meeting

RNS Number : 9173U
Zoetic International PLC
28 November 2019
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

28 November 2019

 

Zoetic International plc

("Zoetic" or the "Company")

 

Result of General Meeting

 

The Company is pleased to announce that at the General Meeting held yesterday all resolutions were passed.

 

Consequently, pursuant to the buy-back agreement that the Company has entered into with Diversion Technologies LLC ("Diversion"), Zoetic has purchased 950,000 ordinary shares of 1 pence each in the Company at a price of 7.80 pence, being the closing mid-market price on 27 November 2019.  No payment will be made to Diversion but, instead, £74,100 will be applied to reduce the debt owed by Diversion to the Company.  Diversion will also make a further payment in cash to extinguish the debt, the amount of which will be determined at the time of settlement of the transaction.

 

Following completion, the purchased ordinary shares will be held in treasury and therefore the total number of ordinary shares in Zoetic with voting rights will be 148,160,034. This figure may be used by Zoetic shareholders as the denominator for calculations to determine if they have a notifiable interest in Zoetic under the Disclosure and Transparency Rules, or if such interest has changed.

 

**ENDS**

 

Enquiries

 

Zoetic International plc                                                                                                 +44 (0) 1738 472 029

Nick Tulloch

 

IFC Advisory Ltd                                                                                                              +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMFDLLLKFFBFBK
UK 100

Latest directors dealings